CAMBRIDGE, Mass.--(BUSINESS WIRE)--Apr. 19, 2022-- Sage Therapeutics, Inc. (Nasdaq: SAGE), a biopharmaceutical company leading the way to create a world with better brain health, announced today that it will host a live webcast on Tuesday, May 3, 2022 at 8:00 a.m. ET to announce first quarter 2022 financial results and discuss recent business updates.

The webcast can be accessed on the Investor page of Sage’s website at investor.sagerx.com. A replay of the webcast will be available approximately two hours after the completion of the event and will be archived for up to 30 days.

About Sage Therapeutics

Sage Therapeutics is a biopharmaceutical company fearlessly leading the way to create a world with better brain health. Our mission is to pioneer solutions to deliver life-changing brain health medicines, so every person can thrive. For more information, please visit. www.sagerx.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220413005785/en/

Investor
Helen Rubinstein
315-382-3979
helen.rubinstein@sagerx.com

Media
Becky Kern
914-772-2310
becky.kern@sagerx.com

Source: Sage Therapeutics, Inc.